Synchronous quadruple primary malignant neoplasms in the thyroid and colorectum in a patient with dMMR Lynch syndrome
This case report describes a rare instance of synchronous quadruple primary malignancies involving the thyroid and colorectum in a 46-year-old man with dMMR Lynch syndrome, emphasizing the critical need for comprehensive pathological and genetic evaluation to distinguish multiple primary tumors from metastatic disease and guide multidisciplinary management.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Cancer is often thought of as a single disease striking one part of the body, but the human body can sometimes develop several distinct cancers at the same time. When two or more separate tumors appear together, doctors call this a synchronous multiple primary malignancy. These are rare events, and when four different cancers arise simultaneously, the occurrence is exceptionally uncommon. A critical factor in understanding such cases is the body's internal repair system. Every cell has a mechanism to fix mistakes that happen when DNA is copied; when this system fails, errors pile up and can lead to cancer. In some families, a genetic defect is passed down that disables this repair system from the start, making individuals highly susceptible to developing multiple tumors at a young age. This condition, known as Lynch syndrome, changes how doctors look for disease and how they treat it, turning a complex medical puzzle into a manageable path for the patient and their family.
In a recent report from the Affiliated Hospital of Shandong Second Medical University, researchers described a case that defies the odds: a 46-year-old man diagnosed with four separate primary cancers at once. The patient had no symptoms that pointed to a specific problem until a routine checkup revealed trouble in two very different places. Ultrasound scans showed a suspicious nodule in his thyroid gland, while a CT scan of his abdomen revealed thickening in the walls of his intestines. Further investigation with a colonoscopy confirmed that the intestinal issues were not just one problem, but three distinct masses located in different sections of the colon. The man also carried a heavy family history of colorectal cancer, with both his father and sister having been affected by the disease.
The medical team decided to remove all the tumors in a single, coordinated surgery. When the pathologists examined the tissue under a microscope, they confirmed that the man indeed had four independent cancers. The first was a papillary thyroid carcinoma in the left side of his neck. The other three were found in the colon: a mucinous adenocarcinoma in the ileocecal region where the small and large intestines meet, a moderately to poorly differentiated adenocarcinoma in the transverse colon, and another similar tumor with mucinous components in the ascending colon. Crucially, the doctors verified that these were not one cancer spreading to other places, but four separate origins. The tumors were in different locations, had different microscopic shapes, and did not show the continuous spread typical of a single disease moving through the body.
To understand why this man developed so many cancers, the team looked deeper into the biology of the tumors. They tested the colorectal cancers for a specific protein pattern that indicates whether the body's DNA repair system is working. The results showed that the tumors lacked two specific proteins, MLH1 and PMS2, which are essential for fixing genetic errors. This absence, known as mismatch repair deficiency, meant the cells were accumulating mutations rapidly. Following this clue, genetic testing of the patient's own DNA revealed a harmful mutation in the MLH1 gene that he had inherited. This confirmed a diagnosis of Lynch syndrome, a hereditary condition that explains his extreme susceptibility to cancer. The presence of this syndrome also provided a clear reason for the family history of colorectal cancer.
After the successful removal of all four tumors, the patient received chemotherapy based on the drug oxaliplatin to help prevent any remaining microscopic cells from growing. The medical team also arranged for genetic counseling, advising that his relatives should be tested for the same genetic mutation so they could take steps to monitor their own health. Six months after the surgery, follow-up scans and tests showed no signs that the cancer had returned or spread. This case serves as a powerful reminder that when a patient presents with multiple tumors, especially at a young age with a family history, doctors must look beyond the immediate disease. By identifying the underlying genetic cause and treating each tumor as a separate entity, a multidisciplinary team can offer a precise diagnosis and a clear path forward, turning a rare and frightening medical situation into a story of successful intervention and future prevention.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.